SARS-CoV-2 viruses and methods of use thereof
Abstract:
This invention relates to SARS-CoV-2 viruses adapted with nanoluciferase reporter molecules and mouse-adapted SARS-CoV-2 viruses, compositions including the same and methods of use thereof.
Public/Granted literature
Information query
Patent Agency Ranking
0/0